This brand name is authorized in Austria, Estonia, Spain, France, Israel, Lithuania, Poland, Singapore, United Kingdom
The drug YTRACIS contains one active pharmaceutical ingredient (API):
|
1
Yttrium ⁹⁰Y chloride
UNII TN98A27Q17 - YTTRIUM CHLORIDE Y-90
|
|
Yttrium (90Y) chloride is produced by decay of its radioactive precursor Strontium (90Sr). It decays by emission of beta radiation of 2.281 MeV (99.98 %) of maximal energy to stable zirconium (90Zr). 90Y-yttrium has a half-life of 2.67 days (64.1 hours). |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| YTRACIS Radiopharmaceutical precursor, solution | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V07AY | Other non-therapeutic auxiliary products | V Various → V07 All other non-therapeutic products → V07A All other non-therapeutic products |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1208214 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 03250001 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 65491383 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 398576 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6748 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1029595 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100126560 |
| Country: SG | Health Sciences Authority | Identifier(s): 13305P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
